Neurology

March 2025 Letter to Shareholders

VANCOUVER, Washington, March 18, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, As envisioned, 2025 is unfolding to be an exciting year…

41 minutes ago

Kane Biotech Secures IRB Approval to Launch Innovative DispersinB® Acne Trial

Kane to work with the University of Miami to study DispersinB® Acne Cleanser in mild to moderate Acne VulgarisWINNIPEG, Manitoba,…

5 days ago

InTandem Capital Partners Announces Strategic Investment in Clinilabs

NEW YORK--(BUSINESS WIRE)--InTandem Capital Partners (“InTandem Capital” or the “Firm”), a healthcare services-focused private equity firm, announced today that it…

6 days ago

Acumen Pharmaceuticals to Present During International Conference on Alzheimer’s and Parkinson’s Diseases 2025 and American Academy of Neurology Annual Meeting

Oral presentations will highlight the implementation of a validated research-use plasma pTau217 assay in the participant screening process for the…

6 days ago

Clario Enters into Definitive Agreement to Acquire WCG’s eCOA Business

Acquisition of WCG's electronic clinical outcome assessments (eCOA) business will expand Clario's scientific expertise and offerings in neuroscience PHILADELPHIA, March 10,…

1 week ago

Adaptive Sound Technologies, Inc. (ASTI) launches their gamma sound and light therapy device, the SOUND+THERAPY, on Walmart.com and Amazon.com

SOUND+THERAPY is a bedside device that uses 40 Hertz gamma sound beats and light flashes to promote better sleep. Studies…

2 weeks ago

MedRhythms Announces FDA Class II Listing for Movive™ to Support Gait Rehabilitation and Motor Function for Parkinson’s Disease

PORTLAND, Maine, March 6, 2025 /PRNewswire/ -- MedRhythms today announced that MR-005, the company's neurorehabilitation system to support gait rehabilitation…

2 weeks ago

Linus Health Achieves Landmark Research Recognition Across Peer-Reviewed Medical and Scientific Journals

Research validates the efficacy and accuracy of its digital solutions designed to detect early indicators of cognitive impairment BOSTON, March…

2 weeks ago

Annexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated Milestones

Robust, Consistent Phase 3 Data and Real-World Evidence Outcomes Support ANX005 as Potential First Targeted Therapy for GBS; Pre-BLA Meeting…

2 weeks ago

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for…

2 weeks ago